Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd Share Price
Equities
600671
CNE000000BF3
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.89 CNY | +4.59% | +11.82% | -23.76% |
Sales 2022 | 109M 15.03M 1.25B | Sales 2023 | 122M 16.81M 1.4B | Capitalization | 1.42B 196M 16.34B |
---|---|---|---|---|---|
Net income 2022 | -67M -9.25M -771M | Net income 2023 | -38M -5.24M -437M | EV / Sales 2022 | 11.3 x |
Net Debt 2022 | 73.65M 10.16M 848M | Net Debt 2023 | 16.8M 2.32M 193M | EV / Sales 2023 | 11.8 x |
P/E ratio 2022 |
-17.3
x | P/E ratio 2023 |
-37.1
x | Employees | 371 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 38.72% |
1 day | +4.59% | ||
1 week | +11.82% | ||
Current month | -2.74% | ||
1 month | -0.78% | ||
3 months | -21.60% | ||
6 months | -14.60% | ||
Current year | -23.76% |
Managers | Title | Age | Since |
---|---|---|---|
Xu Yu Xu
CEO | Chief Executive Officer | 46 | 27/23/27 |
Hong Jian Yu
DFI | Director of Finance/CFO | 46 | 27/23/27 |
Guo Jun Dang
BRD | Director/Board Member | 37 | 26/21/26 |
Members of the board | Title | Age | Since |
---|---|---|---|
Hua Cheng
BRD | Director/Board Member | 55 | 01/92/01 |
Guo Jun Dang
BRD | Director/Board Member | 37 | 26/21/26 |
Hong Jian Yu
DFI | Director of Finance/CFO | 46 | 27/23/27 |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 8.89 | +4.59% | 1,173,353 |
25/24/25 | 8.5 | +1.07% | 455,150 |
24/24/24 | 8.41 | +4.86% | 784,701 |
23/24/23 | 8.02 | -2.08% | 415,201 |
22/24/22 | 8.19 | +3.02% | 1,302,016 |
End-of-day quote Shanghai S.E., April 26, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-23.76% | 149M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- 600671 Stock